Eisai Co., Ltd.
ESALFOTCHealthcare● Active
$28.00
+$4.12(+17.25%)
Market Cap$7.9B
P/E Ratio—
52W High$35.83
52W Low$23.88
Eisai Co., Ltd. (ESALF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ESALF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.07
Est. $0.08 · -192.8%
Revenue
$1.29B
Est. $1.25B · +3.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ESALF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 31, 2026 | $0.37 | — | — | — | $1.34B | — |
| ▼ Q2 FY2026 | May 15, 2026 | $0.08 | -$0.07 | -192.8% | $1.29B | $1.25B | +3.9% |
| ▼ Q1 FY2026 | Feb 9, 2026 | $0.47 | $0.39 | -17.1% | $1.40B | $1.38B | +1.9% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.33 | $0.24 | -26.3% | $1.33B | $1.38B | -3.2% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.27 | $0.36 | +32.8% | $1.41B | $1.36B | +3.6% |
| ▼ Q2 FY2025 | May 13, 2025 | $0.12 | $0.02 | -81.1% | $1.22B | $1.30B | -5.8% |
| ▲ Q1 FY2025 | Feb 4, 2025 | $0.26 | $0.56 | +114.2% | $0.01B | $1.21B | -99.3% |
| ▲ Q4 FY2024 | Nov 8, 2024 | $32.09 | $39.18 | +22.1% | $1.36B | $1.27B | +7.6% |
Q3 FY2026
Jul 31, 2026
EPS Actual
—
EPS Est.
$0.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026Miss
EPS Actual
-$0.07
EPS Est.
$0.08
EPS Surpr.
-192.8%
Revenue
$1.29B
Q1 FY2026
Feb 9, 2026Miss
EPS Actual
$0.39
EPS Est.
$0.47
EPS Surpr.
-17.1%
Revenue
$1.40B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.24
EPS Est.
$0.33
EPS Surpr.
-26.3%
Revenue
$1.33B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.36
EPS Est.
$0.27
EPS Surpr.
+32.8%
Revenue
$1.41B
Q2 FY2025
May 13, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.12
EPS Surpr.
-81.1%
Revenue
$1.22B
Q1 FY2025
Feb 4, 2025Beat
EPS Actual
$0.56
EPS Est.
$0.26
EPS Surpr.
+114.2%
Revenue
$0.01B
Q4 FY2024
Nov 8, 2024Beat
EPS Actual
$39.18
EPS Est.
$32.09
EPS Surpr.
+22.1%
Revenue
$1.36B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $76.92 | $83.57 | $88.64 | 1 |
| Q1 FY2027 | $21.43 | $23.29 | $24.70 | 1 |
| Q4 FY2026 | $61.53 | $66.85 | $70.90 | 1 |
| Q3 FY2026 | $47.84 | $51.98 | $55.13 | 1 |
| Q2 FY2026 | $53.70 | $58.34 | $61.88 | 1 |
| Q1 FY2026 | $11.51 | $12.50 | $13.26 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $217B | $231B | $241B | 2 |
| Q1 FY2027 | $212B | $225B | $236B | 3 |
| Q4 FY2026 | $222B | $236B | $247B | 3 |
| Q3 FY2026 | $199B | $211B | $217B | 4 |
| Q2 FY2026 | $201B | $215B | $228B | 5 |
| Q1 FY2026 | $180B | $199B | $217B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 15, 2026 | -192.8% | $28.76 | $28.76 | +0.00% |
| ▼ Q1 FY2026 | Feb 9, 2026 | -17.1% | $26.76 | $26.76 | +0.00% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -26.3% | $27.36 | $27.36 | +0.00% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +32.8% | $29.00 | $29.00 | +0.00% |
| ▼ Q2 FY2025 | May 13, 2025 | -81.1% | $25.00 | $25.00 | +0.00% |
| ▲ Q1 FY2025 | Feb 4, 2025 | +114.2% | $28.52 | $29.16 | +2.24% |
| ▲ Q4 FY2024 | Nov 8, 2024 | +22.1% | $32.77 | $34.90 | +6.50% |
| ▲ Q3 FY2024 | Aug 2, 2024 | +101.9% | $37.63 | $36.10 | -4.07% |
Q2 FY2026+0.00%
Report Date
May 15, 2026
EPS Beat/Miss
-192.8%
Price Before
$28.76
Price After
$28.76
Q1 FY2026+0.00%
Report Date
Feb 9, 2026
EPS Beat/Miss
-17.1%
Price Before
$26.76
Price After
$26.76
Q4 FY2025+0.00%
Report Date
Nov 6, 2025
EPS Beat/Miss
-26.3%
Price Before
$27.36
Price After
$27.36
Q3 FY2025+0.00%
Report Date
Aug 5, 2025
EPS Beat/Miss
+32.8%
Price Before
$29.00
Price After
$29.00
Q2 FY2025+0.00%
Report Date
May 13, 2025
EPS Beat/Miss
-81.1%
Price Before
$25.00
Price After
$25.00
Q1 FY2025+2.24%
Report Date
Feb 4, 2025
EPS Beat/Miss
+114.2%
Price Before
$28.52
Price After
$29.16
Q4 FY2024+6.50%
Report Date
Nov 8, 2024
EPS Beat/Miss
+22.1%
Price Before
$32.77
Price After
$34.90
Q3 FY2024-4.07%
Report Date
Aug 2, 2024
EPS Beat/Miss
+101.9%
Price Before
$37.63
Price After
$36.10
Avg Beat Reaction+1.17%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+6.50% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ESALF ends December
Eisai Co., Ltd. (ESALF) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.07 — missing the analyst consensus of $0.08 by -192.8%. The next ESALF earnings date is expected around September 1, 2026.
Each quarter, investors track ESALF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ESALF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ESALF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ESALF earnings · 5 questionsEisai Co., Ltd.'s next earnings report is expected around September 1, 2026. ESALF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ESALF historically reports after market close (AMC).
ESALF earnings datewhen is ESALF earningsESALF next earnings datewhen does ESALF report earningsESALF earnings calendar
▸ Source: FMP · Eisai Co., Ltd. SEC filings · US GAAP · Eisai Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026